April 06, 2021
Mike Holmes, PhD, is the Chief Scientific Officer at Ambys Medicines and is joining the QB3-Berkeley Professionals in Residence (PIR) program on April 16th and 23rd. He spoke with PhD student Diana Aguilar Gómez about his career from being a graduate student to industry and his pioneering work in genome editing techniques in gene therapy.
March 01, 2021
Tracy Teal, Ph.D., the executive director of Dryad, speaks about her transition from doing basic research to working in a nonprofit setting.
February 03, 2021
Gary Lee, Ph.D. is the Chief Scientific Officer at Senti Biosciences and former VP of Cell Therapy at Sangamo Therapeutics. Read about his experience in the biotechnology sphere and how graduate students can prepare for a career in industry.
January 05, 2021
Jodi B. Yellin, PhD, the Director of Science Policy at the Association of American Medical Colleges (AAMC) speaks with graduate student Christopher Jackson about her work supporting biomedical research and workforce training, particularly in light of COVID-19.